FSEAX
Price
$62.27
Change
+$0.86 (+1.40%)
Updated
Sep 8 closing price
Net Assets
1.27B
TRASX
Price
$18.19
Change
+$0.25 (+1.39%)
Updated
Sep 8 closing price
Net Assets
72.45M
Interact to see
Advertisement

FSEAX vs TRASX

Header iconFSEAX vs TRASX Comparison
Open Charts FSEAX vs TRASXBanner chart's image
Fidelity Emerging Asia
Price$62.27
Change+$0.86 (+1.40%)
VolumeN/A
Net Assets1.27B
T. Rowe Price Asia Opportunities I
Price$18.19
Change+$0.25 (+1.39%)
VolumeN/A
Net Assets72.45M
FSEAX vs TRASX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSEAX vs. TRASX commentary
Sep 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSEAX is a Buy and TRASX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSEAX has more cash in the bank: 1.27B vs. TRASX (72.5M). TRASX pays higher dividends than FSEAX: TRASX (0.34) vs FSEAX (0.00). FSEAX was incepted earlier than TRASX: FSEAX (32 years) vs TRASX (9 years). TRASX (1.27) is less costly to investors than FSEAX (0.65). TRASX is a more actively managed with annual turnover of: 60.90 vs. FSEAX (57.00). FSEAX has a lower initial minimum investment than TRASX: FSEAX (0) vs TRASX (500000). FSEAX annual gain was more profitable for investors over the last year : 42.71 vs. TRASX (22.63). TRASX return over 5 years is better than : 8.37 vs. FSEAX (1.80).
FSEAXTRASXFSEAX / TRASX
Total Expense Ratio0.650.8378%
Annual Report Gross Expense Ratio0.651.2751%
Fund Existence32 years9 years-
Gain YTD26.20218.502142%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.27B72.5M1,756%
Annual Yield % from dividends0.000.34-
Returns for 1 year42.7122.63189%
Returns for 3 years71.0029.69239%
Returns for 5 years1.808.3721%
Returns for 10 years109.92N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHIO2.120.08
+3.92%
Phio Pharmaceuticals Corp
RF27.040.01
+0.04%
Regions Financial Corp
LGND165.86-0.89
-0.53%
Ligand Pharmaceuticals
OBIO2.73-0.02
-0.73%
Orchestra BioMed Holdings
RLAY4.06-0.06
-1.46%
Relay Therapeutics